Endpoints News
Parsing RFK's latest on vaccines Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
Mon T W Th F
3 August, 2026
The China Biotech Debate: Boston from POST-HOC
The China biotech story is moving fast. On Aug. 6, Endpoints hosts debate-style panels on how China's rise is forcing biotech to rethink innovation, live in Boston. Space is limited. Reserve your spot now.
top stories
1. AstraZeneca-Bristol Myers megamerger talk leaves Wall Street wanting more answers
2. RFK Jr. interview sparks corrections on vaccines, pandemics and measles
3.
in focus
Work ethic becomes a flashpoint as China's biotech pace quickens
4. FDA expands Pluvicto label, making it available to most metastatic prostate cancer patients
5. Amgen says hackers stole patient data in cloud breach
6. Update: Supernus, Indivior to merge and form CNS-focused drugmaker
more stories
 
Kevin Miller
.

Reports that AstraZeneca and Bristol Myers Squibb have discussed a possible merger have left analysts scratching their heads for a reason, Max Gelman writes.

.
Kevin Miller
Deputy Editor, Endpoints News
1
by Max Gelman

The week­end re­portabout a po­ten­tial megamerg­er of As­traZeneca and Bris­tol My­ers Squibb is rais­ing a num­ber of ques­tions for both com­pa­nies, ac­cord­ing to bio­phar­ma...

Read the full story
Endpoints 11 - Reserve Your Spot - Save $100 with our Early Bird rate
One night, one room: the founders, scientists and investors behind the Endpoints 11, together in Boston this September. Reserve your spot now and save with the early bird rate.
HHS Secretary Robert F. Kennedy Jr. (Olivier Douliery/Abaca/Sipa USA via AP Images)
2
by Zachary Brennan

HHS Sec­re­tary Robert F. Kennedy Jr. dou­bled down Sun­day on his de­fense of the Trump ad­min­is­tra­tion and crit­i­cism of vac­cine re­search, though he did de­clare...

Read the full story
.
Researchers in a lab at Huahui Health in Beijing, May 30, 2026 (Qilai Shen/Bloomberg via Getty Images)
Endpoints In Focus
3
by Kyle LaHucik

She­fali Agar­w­al works con­stant­ly.

“I’m very pas­sion­ate about what I do. I love get­ting good drugs to pa­tients, so I work a lot,” Agar­w­al, the...

Read the full story
4
by Lei Lei Wu

The FDA ap­proved No­var­tis’ ra­dio­phar­ma drug Plu­vic­to for use along­side hor­mone ther­a­py, mak­ing the drug avail­able to many more pa­tients.

The ap­proval near­ly dou­bles the...

Read the full story
5
by Ayisha Sharma

Am­gen said Fri­day that hack­ers have stolen com­pa­ny and pa­tient in­for­ma­tion in a da­ta breach.

The com­pa­ny said it no­ticed “unau­tho­rized ac­tiv­i­ty” af­fect­ing da­ta stored...

Read the full story
6
by Ayisha Sharma

Su­per­nus and In­di­v­ior have signed an all-stock merg­er agree­ment to es­tab­lish a new com­pa­ny that they be­lieve could be a leader in cen­tral ner­vous sys­tem...

Read the full story